Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

D. Aletaha, Tuhina Neogi, Alan J. Silman et al. · Annals of the Rheumatic Diseases · 2010 · 4.9K citations · Full text

Medicine, Internal Medicine, Clinical Classification Systems +13

Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

William J. Taylor, Dafna D. Gladman, Philip Helliwell et al. · Arthritis & Rheumatism · 2006 · 3.7K citations

Medicine, Biostatistics, Clinical Sciences +16

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2009 · 3.6K citations · Full text

Medicine, Radiology, Musculoskeletal Medicine +11

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

Martín Rudwaleit, D. van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2010 · 1.7K citations · Full text

Medicine, Dermatology, Internal Medicine +16

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study

Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease et al. · Arthritis & Rheumatism · 2009 · 603 citations

Medicine, Clinical Sciences, Pharmacotherapy +15